The Rising Influence of Specialty in the Retail Pharmacy World - Oct 2023
Drug prices continue to increase at a steady rate as the development and use of specialty drugs continue to grow. In this presentation, we’ll share key trends impacting drug pricing and drug access today, including the growth of specialty drugs in the retail chain, the uptake of biosimilars, and payer-mandated policies such as white bagging. This presentation will also feature drug price inflation rates by class of trade and therapeutic area from the Vizient Pharmacy Market Outlook.
Target Audience
- Pharmacists
- Pharmacy Technicians
- Other Healthcare Professionals
Learning Objectives
Pharmacists learning objectives:
At the conclusion of this activity, pharmacists should be able to:
- Identify characteristics of self-administered medications that are distributed through specialty channels.
- Describe the cost and spending implications of specialty medications on health-system pharmacy budgets.
- Compare and contrast the impact of policy on health-system specialty pharmacy (eg, 340B, white bagging).
- Anticipate growth in specialty based on retail medications in the FDA pipeline.
Pharmacy technician learning objectives:
At the conclusion of this activity, pharmacy technicians should be able to:
- Identify characteristics of self-administered medications that are distributed through specialty channels.
- Describe the cost and spending implications of specialty medications on health-system pharmacy budgets.
- Compare and contrast the impact of policy on health-system specialty pharmacy (eg, 340B, white bagging).
- Anticipate growth in specialty based on retail medications in the FDA pipeline.
Additional Information
Attachment | Size |
---|---|
Helpful Tips for Users - Vizient CE System.pdf | 134.66 KB |
Faculty
Planning Committee
Mitch Brown, PharmD
Pharmacy Executive
Vizient, Inc
Sarah Dosher, MBA, CPHQ, RHIA
Project Manager
Vizient, Inc
Erika Johnston
Project Manager
Vizient, Inc
Faculty
Pharmacy Executive
Vizient, Inc
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty
Statement of content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Off-label/unapproved drug uses or products are mentioned within this activity.
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Designation Statement(s)
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
UAN JA0006103-0000-23-301-L04-P
UAN JA0006103-0000-23-301-L04-T
OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance